WRF
ARIA

Waddell & Reed Financial’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Waddell & Reed Financial’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-5,753,900
Closed -$106M – 597
2013
Q3 		$106M Buy
5,753,900
+269,600
+5% +$5.23M 0.2% 129
2013
Q2 		$95.9M Buy
+5,484,300
New +$97.2M 0.2% 124

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Waddell & Reed Financial's ARIA Position: Q4 2013 in Review

Waddell & Reed Financial sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2013, closing a stake of 5,753,900 shares — an estimated $106M sold.

Waddell & Reed Financial first reported a position in ARIA in Q2 2013 and held it in 2 quarters. The position peaked at $106M in Q3 2013. 166 funds tracked by Wall St. Rank hold ARIA as of Q4 2013.

  • Waddell & Reed Financial reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2013 after selling out during the quarter.
  • Waddell & Reed Financial sold 5,753,900 Ariad Pharmaceuticals Inc shares in Q4 2013, an estimated $106M.
  • Waddell & Reed Financial first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 2 quarters.
  • Waddell & Reed Financial's Ariad Pharmaceuticals Inc position peaked at $106M in Q3 2013.
  • 166 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2013.

Based on Waddell & Reed Financial's 13F filing for Q4 2013, filed 14 Feb 2014.